Castle Biosciences (CSTL) Other Working Capital Changes (2018 - 2026)
Castle Biosciences' Other Working Capital Changes history spans 8 years, with the latest figure at -$5.8 million for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 1066.72% to -$5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 million, a 386.64% decrease, with the full-year FY2025 number at -$1.3 million, down 386.64% from a year prior.
- Other Working Capital Changes hit -$5.8 million in Q4 2025 for Castle Biosciences, down from -$161000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for CSTL hit a ceiling of $5.2 million in Q2 2025 and a floor of -$5.8 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$482650.0 across 5 years, with a median of -$137500.0 in 2022.
- Biggest five-year swings in Other Working Capital Changes: plummeted 1401.55% in 2021 and later soared 2634.03% in 2025.
- Tracing CSTL's Other Working Capital Changes over 5 years: stood at -$3.0 million in 2021, then skyrocketed by 98.03% to -$59000.0 in 2022, then surged by 32.2% to -$40000.0 in 2023, then surged by 1602.5% to $601000.0 in 2024, then tumbled by 1066.72% to -$5.8 million in 2025.
- Business Quant data shows Other Working Capital Changes for CSTL at -$5.8 million in Q4 2025, -$161000.0 in Q3 2025, and $5.2 million in Q2 2025.